Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by OPTSALESon Nov 28, 2012 11:30am

106 Views

Post# 20654701

RE: RE: Barchart

interesting

RBC

NPC's MACD is providing a weak bearish signal. Although the indicator is above the critical level of 0 which means that the underlying moving averages are bullish, the MACD has crossed below the 9-day moving average or signal line. This means that positive momentum has begun to slow and the stock may trend lower

Bullboard Posts

New Found Gold begins surface trenching at Queensway